In this study we provide evidence that loss of the scaffold protein Nedd9 is sufficient to significantly delay CLL onset, impair leukemic infiltration, and prolong survival of the CLL mice. This evidence concerns the gene NEDD9 and B-cell chronic lymphocytic leukemia.